The findings have been printed on-line Nov. 9 in JAMA Inside Medication.
The dangers to important staff in all disciplines who couldn’t make money working from home have been clear from the start of the pandemic, mentioned Dr. Robert Glatter, an emergency drugs doctor at Lenox Hill Hospital in New York Metropolis.
“However the threat of transmission to family members residing with important staff grew to become equally essential when contemplating potential for illness development together with group transmission,” Glatter mentioned.
Since scientists know that asymptomatic transmission of the virus is a significant means it spreads, steps like self-isolation and self-quarantining in separate rooms within the dwelling, together with carrying masks, would possibly scale back the danger of transmission, he famous.
An alternative choice contains having important staff self-quarantine or self-isolate in lodge rooms, which might considerably scale back the danger to family members, Glatter added.
“Family members who’re overweight, smoke, [are] older than 65, have diabetes, coronary heart illness, power kidney illness, asthma or COPD are at a lot greater threat for antagonistic outcomes — together with dying — in the event that they contract COVID-19,” Glatter mentioned.
It is vital to issue within the elevated threat to family members “when assessing general potential for group transmission and illness development of COVID-19 amongst important staff who cannot make money working from home,” he harassed.
Selden hopes these findings will assist policymakers when which are making choices in regards to the economic system and public well being.
“To the extent that we will scale back the prevalence of COVID-19 in our communities via a mix of widespread sense, vigorous public well being and, finally, a vaccine, then we will scale back the extent to which policymakers have to decide on between the economic system and maintaining the inhabitants protected,” Selden mentioned.
For extra on COVID-19, head to the U.S. Centers for Disease Control and Prevention.
SOURCES: Thomas Selden, PhD, Heart for Financing, Entry and Price Developments, U.S. Company for Healthcare Analysis and High quality, Rockville, Md.; Robert Glatter, MD, emergency drugs doctor, Lenox Hill Hospital, New York Metropolis; JAMA Inside Medication, Nov. 9, 2020, on-line